back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-03-30 14:10 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$318,000
+75,000 vol $4.24 each |
75,000 | |
| Filed 2021-03-30 14:09 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-1,667 vol |
0 | |
| Filed 2020-01-03 15:39 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-13,266,917 vol |
44,370 | |
| Filed 2020-01-03 15:38 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-69,767 vol |
233 | |
| Filed 2020-01-03 15:36 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-6,977 vol |
||
| Filed 2020-01-03 15:34 Tx date 2020-01-03 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-22,424,985
-498,333 vol $45.00 each |
1,667 | |
| Filed 2018-03-02 Tx date 2018-03-01 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
500,000 | |
| Filed 2018-03-02 Tx date 2018-02-28 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
0 | |
| Filed 2016-10-17 Tx date 2016-10-17 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,842.50
-28,500 vol $0.205 each |
13,832,787 | |
| Filed 2016-10-17 Tx date 2016-10-17 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-104,300
-521,500 vol $0.20 each |
13,311,287 | |
| Filed 2016-10-17 Tx date 2016-10-13 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,947.50
-9,500 vol $0.205 each |
13,862,287 | |
| Filed 2016-10-17 Tx date 2016-10-17 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-210.00
-1,000 vol $0.21 each |
13,861,287 | |
| Filed 2016-01-27 Tx date 2014-11-25 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-27 Tx date 2016-01-25 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-17,500
-70,000 vol $0.25 each |
13,871,787 | |
| Filed 2016-01-27 Tx date 2016-01-25 |
$BCT
BriaCell Therapeutics Corp. |
WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$17,500
+70,000 vol $0.25 each |
70,000 |